|
Zynex ، Inc. (Zyxi) تقييم DCF
US | Healthcare | Medical - Distribution | NASDAQ
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Zynex, Inc. (ZYXI) Bundle
هندسة من أجل الدقة ، تمكنك حاسبة Zynex ، Inc. (Zyxi) DCF من تقييم Zynex ، Inc. (Zyxi) باستخدام البيانات المالية الفعلية وتوفر مرونة كاملة لتعديل جميع المعلمات الأساسية للتوقعات المحسنة.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 45.5 | 80.1 | 130.3 | 158.2 | 184.3 | 197.2 | 211.1 | 225.9 | 241.7 | 258.7 |
| Revenue Growth, % | 0 | 76.2 | 62.63 | 21.39 | 16.54 | 7.01 | 7.01 | 7.01 | 7.01 | 7.01 |
| EBITDA | 11.8 | 11.7 | 22.4 | 26.2 | 17.9 | 33.2 | 35.5 | 38.0 | 40.7 | 43.5 |
| EBITDA, % | 26.05 | 14.66 | 17.16 | 16.55 | 9.71 | 16.83 | 16.83 | 16.83 | 16.83 | 16.83 |
| Depreciation | .8 | 1.6 | 3.7 | 3.9 | 4.2 | 4.4 | 4.8 | 5.1 | 5.5 | 5.8 |
| Depreciation, % | 1.71 | 1.96 | 2.83 | 2.48 | 2.29 | 2.26 | 2.26 | 2.26 | 2.26 | 2.26 |
| EBIT | 11.1 | 10.2 | 18.7 | 22.3 | 13.7 | 28.7 | 30.8 | 32.9 | 35.2 | 37.7 |
| EBIT, % | 24.34 | 12.7 | 14.34 | 14.07 | 7.42 | 14.57 | 14.57 | 14.57 | 14.57 | 14.57 |
| Total Cash | 14.0 | 39.2 | 42.6 | 20.1 | 44.6 | 58.9 | 63.1 | 67.5 | 72.2 | 77.3 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 5.8 | 13.8 | 28.6 | 35.1 | 26.8 | 35.0 | 37.5 | 40.1 | 42.9 | 45.9 |
| Account Receivables, % | 12.83 | 17.27 | 21.97 | 22.17 | 14.56 | 17.76 | 17.76 | 17.76 | 17.76 | 17.76 |
| Inventories | 2.4 | 8.6 | 10.8 | 13.5 | 13.1 | 15.7 | 16.8 | 18.0 | 19.3 | 20.6 |
| Inventories, % | 5.23 | 10.78 | 8.25 | 8.53 | 7.11 | 7.98 | 7.98 | 7.98 | 7.98 | 7.98 |
| Accounts Payable | 2.1 | 4.7 | 4.7 | 5.6 | 8.4 | 8.8 | 9.4 | 10.1 | 10.8 | 11.6 |
| Accounts Payable, % | 4.71 | 5.89 | 3.64 | 3.55 | 4.58 | 4.47 | 4.47 | 4.47 | 4.47 | 4.47 |
| Capital Expenditure | -.2 | -1.0 | -.6 | -.4 | -1.2 | -1.2 | -1.3 | -1.3 | -1.4 | -1.5 |
| Capital Expenditure, % | -0.35186 | -1.23 | -0.46738 | -0.26428 | -0.65429 | -0.59344 | -0.59344 | -0.59344 | -0.59344 | -0.59344 |
| Tax Rate, % | 22.63 | 22.63 | 22.63 | 22.63 | 22.63 | 22.63 | 22.63 | 22.63 | 22.63 | 22.63 |
| EBITAT | 8.8 | 9.1 | 14.3 | 17.1 | 10.6 | 23.0 | 24.6 | 26.3 | 28.2 | 30.1 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | 3.3 | -2.0 | .5 | 12.3 | 25.0 | 15.8 | 25.2 | 26.9 | 28.8 | 30.8 |
| WACC, % | 5.85 | 5.94 | 5.82 | 5.82 | 5.83 | 5.85 | 5.85 | 5.85 | 5.85 | 5.85 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 106.3 | |||||||||
| Long Term Growth Rate, % | 4.00 | |||||||||
| Free cash flow (T + 1) | 32 | |||||||||
| Terminal Value | 1,731 | |||||||||
| Present Terminal Value | 1,303 | |||||||||
| Enterprise Value | 1,409 | |||||||||
| Net Debt | 32 | |||||||||
| Equity Value | 1,377 | |||||||||
| Diluted Shares Outstanding, MM | 36 | |||||||||
| Equity Value Per Share | 38.10 |
What You Will Get
- Real ZYXI Financial Data: Pre-filled with Zynex, Inc.'s historical and projected data for precise analysis.
- Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
- Automatic Calculations: See Zynex, Inc.'s intrinsic value update instantly based on your changes.
- Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
- User-Friendly Design: Simple structure and clear instructions for all experience levels.
Key Features
- Comprehensive DCF Calculator: Features detailed unlevered and levered DCF valuation models tailored for Zynex, Inc. (ZYXI).
- WACC Calculator: Pre-configured Weighted Average Cost of Capital sheet with adjustable inputs specific to Zynex.
- Customizable Forecast Assumptions: Adjust growth rates, capital expenditures, and discount rates to fit Zynex's financial outlook.
- Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios pertinent to Zynex, Inc. (ZYXI).
- Interactive Dashboard and Charts: Visual representations summarize essential valuation metrics for streamlined analysis of Zynex.
How It Works
- Download the Template: Gain immediate access to the Excel-based Zynex, Inc. (ZYXI) DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and other variables.
- Instant Calculations: The model automatically recalculates Zynex’s intrinsic value.
- Test Scenarios: Experiment with various assumptions to assess potential changes in valuation.
- Analyze and Decide: Utilize the results to inform your investment or financial strategy.
Why Choose This Calculator for Zynex, Inc. (ZYXI)?
- Accurate Data: Up-to-date Zynex financials provide trustworthy valuation outcomes.
- Customizable: Modify essential parameters such as growth rates, WACC, and tax rates to align with your forecasts.
- Time-Saving: Ready-made calculations save you from starting from scratch.
- Professional-Grade Tool: Tailored for investors, analysts, and consultants in the healthcare sector.
- User-Friendly: Easy-to-navigate design and clear instructions ensure accessibility for all users.
Who Should Use This Product?
- Healthcare Professionals: Develop comprehensive and accurate financial models for medical device investments.
- Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decisions in the healthcare sector.
- Consultants and Advisors: Offer clients precise valuation assessments for Zynex, Inc. (ZYXI) stock.
- Students and Educators: Utilize real-world financial data to enhance learning in valuation and modeling techniques.
- Investors in Medical Technology: Gain insights into the valuation methodologies of innovative companies like Zynex, Inc. (ZYXI).
What the Template Contains
- Pre-Filled Data: Includes Zynex, Inc.'s historical financials and forecasts.
- Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
- Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
- Key Financial Ratios: Analyze Zynex, Inc.'s profitability, efficiency, and leverage.
- Customizable Inputs: Edit revenue growth, margins, and tax rates with ease.
- Clear Dashboard: Charts and tables summarizing key valuation results.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.